| Logo Mark EMERGENT BIOSOLUTIONS CANADA INC.
87203685 14 Oct 2016 | on 31 Jul 2024
| Pharmaceutical preparations for diseases and conditions associated wit... Class 005 Class 005 Pharmaceutical Products The mark consists of three tiered orange oblong shapes with the second oblong longer than the other two, with a single yellow ring in the first oblong; three yellow rings in the second oblong; and a single ring that is red and yellow in the third oblong. The white background is not a claimed feature of the mark. | | | BAT EMERGENT BIOSOLUTIONS CANADA INC.
85751909 11 Oct 2012 | on 09 Jun 2024
| Pharmaceutical preparations containing antibodies against botulinum to... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations containing antibodies against botulinum toxin and therapeutic preparations for treating botulinum toxicity | | | ANTHRASIL EMERGENT BIOSOLUTIONS CANADA INC.
86319102 24 Jun 2014 | on 22 Jun 2023
| Pharmaceutical and veterinary preparations for diseases and conditions... Class 005 Class 005 Pharmaceutical Products Pharmaceutical and veterinary preparations for diseases and conditions associated with exposure to B. anthracis organisms or spores | | | CANGENE EMERGENT BIOSOLUTIONS CANADA INC.
75139286 24 Jul 1996 | on 01 Nov 2018
| pharmaceutical preparations for the treatment of blood or hematologica... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for the treatment of blood or hematological or immunological disorders | | | CNJ-016 EMERGENT BIOSOLUTIONS CANADA INC.
78311014 08 Oct 2003 | on 05 Jan 2018
| Plasma Products, namely, a Vaccinia Immune Globulin used for the Thera... Class 005 Class 005 Pharmaceutical Products Plasma Products, namely, a Vaccinia Immune Globulin used for the Therapeutic Treatment of Naturally Occurring Orthopox Viruses and/or Genetically related Recombinant Micro-Organisms | | | EMHIGLO Emergent BioSolutions Canada Inc.
90560762 04 Mar 2021 | on 31 Jul 2023 | blood plasma derivatives and immunoglobulin preparations for therapeut... Class 005 Class 005 Pharmaceutical Products blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against COVID-19 | | | COPLEZDI Emergent BioSolutions Canada Inc.
90560770 04 Mar 2021 | on 31 Jul 2023 | blood plasma derivatives and immunoglobulin preparations for therapeut... Class 005 Class 005 Pharmaceutical Products blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against COVID-19 | | | HIGRALY Emergent BioSolutions Canada Inc.
90560772 04 Mar 2021 | on 31 Jul 2023 | blood plasma derivatives and immunoglobulin preparations for therapeut... Class 005 Class 005 Pharmaceutical Products blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against COVID-19 | | | VELZUVIX Emergent BioSolutions Canada Inc.
90560755 04 Mar 2021 | on 31 Jul 2023 | blood plasma derivatives and immunoglobulin preparations for therapeut... Class 005 Class 005 Pharmaceutical Products blood plasma derivatives and immunoglobulin preparations for therapeutic treatment against COVID-19 | | | CANGENE EMERGENT BIOSOLUTIONS CANADA INC.
85081044 09 Jul 2010 | on 03 Sep 2021 | Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from ... Class 005 Class 005 Pharmaceutical Products Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from Human and Animal Sources for Use in Treating Infectious Diseases, Blood Disorders and Immunological Diseases; and Recombinant Protein Based Pharmaceutical Products for Treating Hormone Deficiency, Radiation Exposure and Oncology Related Diseases | | 
